Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Goodwill & Intangibles: 2018-2025

Historic Goodwill & Intangibles for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $1.3 billion.

  • Dr Reddys Laboratories' Goodwill & Intangibles rose 157.49% to $1.3 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $1.3 billion, marking a year-over-year increase of 157.49%. This contributed to the annual value of $1.3 billion for FY2025, which is 157.49% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Goodwill & Intangibles stood at $1.3 billion for FY2025, which was up 157.49% from $494.0 million recorded in FY2024.
  • In the past 5 years, Dr Reddys Laboratories' Goodwill & Intangibles registered a high of $1.3 billion during FY2025, and its lowest value of $417.0 million during FY2022.
  • Over the past 3 years, Dr Reddys Laboratories' median Goodwill & Intangibles value was $494.0 million (recorded in 2024), while the average stood at $731.0 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first dropped by 24.04% in 2022, then surged by 157.49% in 2025.
  • Dr Reddys Laboratories' Goodwill & Intangibles (Yearly) stood at $549.0 million in 2021, then fell by 24.04% to $417.0 million in 2022, then climbed by 2.40% to $427.0 million in 2023, then increased by 15.69% to $494.0 million in 2024, then surged by 157.49% to $1.3 billion in 2025.